Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Receivables (2021 - 2025)

Biote (BTMD) has 5 years of Change in Receivables data on record, last reported at -$479000.0 in Q3 2025.

  • For Q3 2025, Change in Receivables fell 155.31% year-over-year to -$479000.0; the TTM value through Sep 2025 reached $1.6 million, up 311.04%, while the annual FY2024 figure was $2.3 million, 348.91% up from the prior year.
  • Change in Receivables reached -$479000.0 in Q3 2025 per BTMD's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.7 million in Q3 2023 and bottomed at -$3.3 million in Q4 2023.
  • Average Change in Receivables over 5 years is $342058.8, with a median of $542000.0 recorded in 2022.
  • The widest YoY moves for Change in Receivables: up 362.99% in 2023, down 426.74% in 2023.
  • A 5-year view of Change in Receivables shows it stood at -$671000.0 in 2021, then rose by 5.81% to -$632000.0 in 2022, then crashed by 426.74% to -$3.3 million in 2023, then soared by 91.5% to -$283000.0 in 2024, then tumbled by 69.26% to -$479000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$479000.0 in Q3 2025, $1.5 million in Q2 2025, and $907000.0 in Q1 2025.